Austin J.A. (1998) Why patients use alternative medicine: results of a national study. JAMA
279, 1548–1553.
Article
Google Scholar
Berkson B.M. (1999) A conservative triple antioxidant approach to the treatment of hepatitis C. Combination of alpha lipoic acid (thioctic acid), silymarin, and selenium: three case histories. Med. Klin.
94, S84-S89.
Article
Google Scholar
Brevoort P. (1996) The U.S. botanical market: an overview. Herbalgram
36, 49–57.
Google Scholar
Dehmlow C., Murawski N., and de Groot H. (1996) Scavengering of reactive oxygen species and inhibition arachidonic acid metabolism by silibinin in human cells. Life Sci.
58, 1591–1600.
PubMed
Article
CAS
Google Scholar
Deshmukh, M. and Johnson E.M. Jr. (1997) Programmed cell death in neurons: focus on the pathway of nerve growth factor deprivation-induced death of sympathetic neurons. Mol. Pharmacol.
51, 897–906.
PubMed
CAS
Google Scholar
Eisenberg D.M., Kessler R.C., Foster C., Norlock F.E., Calkins D.R., and Delbanco T.L. (1993) Unconventional medicine in the United States: prevalence, costs, and patterns of use. N. Engl. J. Med.
328, 246–252.
PubMed
Article
CAS
Google Scholar
Ferenci P. and Dragosics B. (1989) Randomized controlled trial of silymarin treatment in patients with cirrhosis of liver. J. Hepatol.
9, 105–113.
PubMed
Article
CAS
Google Scholar
Flora K., Hahn M., Rosen H., and Benner K. (1998) Milk Thistle (Silybum marianum) for the therapy of liver disease. Am. J. Gastroenterol.
93, 139–143.
PubMed
Article
CAS
Google Scholar
Katiyar S.K., Korman N.J., Mukhtar H., and Agarwal R. (1997) Protective effects of silymarin against photocarcinogenesis in a mouse skin model. J. Natl. Cancer Inst.
89, 556–566.
PubMed
Article
CAS
Google Scholar
Kruman I., Bruce-Keller J.N., Fernandez S., and Mattson M.P. (1997) Evidence that 4-hydroxynonenal mediates oxidative stress-induced neuronal apoptosis. J. Neurosci.
17, 5089–5100.
PubMed
CAS
Google Scholar
Luper, S. (1999) A review of plants used in the treatment of liver disease: part two. Altern. Med Rev.
4(3), 178–88.
PubMed
CAS
Google Scholar
Manna, S.K., Mukhopadhyay, A., Van, N.T., and Aggarwal, B.B. (1999) Silymarin suppress TNF-induced activation of NF-κB, c-Jun N-terminal kinase, and apoptosis. J. Immunol.
163, 6800–6809.
PubMed
CAS
Google Scholar
Mathur A. and Vallano M.L. (2000) 2,2′,3,3′,4,4′-Hexahydroxy-1,1′-biphenyl-6,6′-dimethanol Dimethyl Ether (HBDDE)-induced neuronal apoptosis independent of classical protein kinase C α or λ inhibition. Biochem. Pharmacol.
60, 809–815.
PubMed
Article
CAS
Google Scholar
Mattson, M.P., Cheng, B., Culwell, A.R., Esch, F.S., Lieberburg, I., and Rydel, R.E. (1993) Evidence for excitoprotective and intraneuronal calcium-regulating roles for secreted forms of the beta-amyloid precursor protein. Neuron
10, 243–254.
PubMed
Article
CAS
Google Scholar
Mattson M.P. (1998) Modification of ion homeostasis by lipid peroxidation: roles in neuronal degeneration and adaptive plasticity. Trends Neurosci.
21, 53–57.
PubMed
Article
CAS
Google Scholar
Mosmann, T. (1997) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods
65, 55–63.
Article
Google Scholar
Muzes, G., Deak, G., Lang, I., Nekam, K., Gergely, P., and Fiher, J. (1991) Effect of the bioflavonoid silymarin on the in vitro activity and expression of superoxide dismutase (SOD) enzyme. Acta Physiol. Hung.
78, 3–9.
PubMed
CAS
Google Scholar
Park, D.S., Stefanis, L., Yan, C.Y., Farinelli, S.E., and Greene, L.A. (1996) Ordering the cell death pathway. Differential effects of BCL2, an interleukin-1-converting enzyme family protease inhibitor, and other survival agents on JNK activation in serum/nerve growth factor-deprived PC12 cells. J. Biol. Chem.
271, 21898–21905.
PubMed
Article
CAS
Google Scholar
Scambia G., De Vincenzo R., Ranelletti F.O., Benedetti-Panici P., Ferrandina G., et al. (1996) Antiproliferative effect of silybin on gynaecological malignancies: synergism with cisplatin and doxorubicin. Eur. J. Cancer
32A, 877–882.
PubMed
Article
CAS
Google Scholar
Schonfeld J.V., Weisbrod B., and Muller M.K. (1997) Silibinin, a plant extract with antioxidant and membrane stabilizing properties, protects exocrine pancrease from cyclosporin A toxicity. Cell Mol Life Sci.
563, 917–920.
Article
Google Scholar
Soliman K.F. and Mazzio E.A. (1998) In vitro attenuation of nitric oxide production in C6 astrocyte cell culture by various dietary compounds. Proc. Soc. Exp. Biol. Med.
218, 390–397.
PubMed
CAS
Google Scholar
Tager M., Dietzmann J., Thiel U., Hinrich Neumann K., and Ansorge S. (2001) Restoration of the cellular thiol status of peritoneal macrophages from CAPD patients by the flavonoids silibinin and silymarin. Free Radic. Res.
34, 137–151.
PubMed
Article
CAS
Google Scholar
Valenzuela A., Guerra R., and Videla L.A. (1986) Antioxidant properties of the flavonoids silybin and (+)-cyanidanol-3: comparison with butylated hydroxyanisole and butylated hydroxytoluene. Planta Med.
6, 438–440
PubMed
Article
Google Scholar
Venkataramanan R., Ramachandran V., Komoroski B.J., Zhang S., Schiff P.L., and Strom S.C. (2000) Milk thistle, a herbal supplement, decreases the activity of CYP3A4 and uridine diphosphoglucuronosyl transferase in human hepatocyte cultures. Drug Metab. Dispos.
28, 1270–1273.
PubMed
CAS
Google Scholar
Zhao J., Sharma Y., and Agarwal R. (1999) Significant inhibition by the Flavinoid antioxidant Silymarin against 12-O-tetradecanoylphorbol 13-Acetate caused modulation of antioxidant and inflammatory enzymes and Cyclooxygenase 2 and Interleukin-1α expression in SENCAR mouse epidermis: implications in the prevention of stage I tumor promotion. Mol. Carcinogen.
26, 321–333.
Article
CAS
Google Scholar
Zi X., and Agarwal R. (1999) Silibinin decreases prostate-specific antigen with cell growth inhibition via G1 arrest, leading to differentiation of prostate carcinoma cells: implications for prostate cancer intervention. Proc. Natl. Acad. Sci. USA
96, 7490–7495.
PubMed
Article
CAS
Google Scholar